[1] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
[2] |
Liu Jing, Liu Qin, Huang Mei.
Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm
[J]. Journal of International Oncology, 2024, 51(5): 267-273.
|
[3] |
Wan Fang, Yang Gang, Li Rui, Wan Qijing.
Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer
[J]. Journal of International Oncology, 2024, 51(4): 204-209.
|
[4] |
Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.
Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients
[J]. Journal of International Oncology, 2024, 51(1): 37-42.
|
[5] |
Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.
Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma (2023 Edition)
[J]. Journal of International Oncology, 2023, 50(7): 385-397.
|
[6] |
Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong.
Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer
[J]. Journal of International Oncology, 2023, 50(2): 76-81.
|
[7] |
Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng.
Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy
[J]. Journal of International Oncology, 2023, 50(12): 745-750.
|
[8] |
Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei.
Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2022, 49(8): 464-472.
|
[9] |
Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian.
Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN+ esophageal squamous cell carcinoma patients
[J]. Journal of International Oncology, 2022, 49(6): 334-339.
|
[10] |
Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong.
Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer
[J]. Journal of International Oncology, 2022, 49(4): 199-205.
|
[11] |
Zhou Jianfeng, Wang Tiejun.
Targeted therapy and immunotherapy of esophageal cancer
[J]. Journal of International Oncology, 2022, 49(4): 237-242.
|
[12] |
Liu Jia, Ge Xiaolin, Di Xiaoke, Shi Yujing, Zeng Yuting.
Efficacy analysis of Xiyanping injection on prevention of radioactive esophagitis
[J]. Journal of International Oncology, 2022, 49(3): 146-150.
|
[13] |
Zhang Junpeng, Yu Yanyan, Li Baosheng.
Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2022, 49(3): 185-189.
|
[14] |
Geng Hui, Hu Fengchao, Lu Hongchao, Guo Jungang, Qi Zengping.
Effects of TPF regimen and IMRT on immune function and survival prognosis of patients with advanced esophageal cancer
[J]. Journal of International Oncology, 2022, 49(2): 84-88.
|
[15] |
Guo Xinwei, Zhang Han, Ye Hongxun, Liu Yangchen, Ji Shengjun, Zhou Shaobing, Zhou Juying.
Influence of preoperative Naples prognostic score on prognosis of patients with thoracic esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2022, 49(2): 89-94.
|